News & Views

BRAIN Biotech AG published in mid-June its first sustainability report and initial ESG data. We asked our colleague Michael Schneiders, Head of IR and Sustainability, about the background, challenges and next steps in sustainability at BRAIN.

Due to the ongoing pandemic BRAIN Biotech AG had to choose a virtual format for its Annual General Meeting.

BRAIN Biotech AG and Formo Bio GmbH are launching a strategic collaboration to further advance the production of animal-free milk proteins

BRAIN has acquired Breatec B.V. including the Comix business to further enhance the growth trajectory of BRAIN’s BioIndustrial division and expand its enzyme portfolio to adjacent market segments.

BRAIN Group company Analyticon Discovery extends its collaboration with clinical-stage company Pharvaris, focused on bringing oral bradykinin-B2-receptor antagonist small molecules to patients.

On January 17 BRAIN Biotech AG has published its Annual Report including the detailed consolidated financial statements for the fiscal year 2020/21.